Crossmark

At least one hyperkalemia episode is associated with mortality and disease progression in stage 3 CKD patients

Crossref DOI link: https://doi.org/10.1007/s40620-023-01647-3

Published Online: 2023-06-12

Published Print: 2023-12-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Falcão, Luis https://orcid.org/0000-0001-8303-5134
Raimundo, Mário

Fernandes, Sara

Fernandes, Adriana

Donato, Beatriz

Macedo, Ana

Costa, Ana Cortesão

Teixeira, Catarina

Silva, Sónia

de Almeida, Edgar A. F.
Funding

Funding for this research was provided by:

Vifor Pharma

Vifor Pharma
License Information

Version of Record valid from 2023-06-12

Text and Data Mining valid from 2023-06-12

Version of Record valid from 2023-06-12
More Information

Article History

Received: 18 December 2022

Accepted: 10 April 2023

First Online: 12 June 2023

Declarations

:

: The authors have no conflicts of interest to declare.

: The study protocol has been approved by the Ethics Committee of Hospital Beatriz Ângelo.